Treatment of hypertension in the elderly in 2017/2018 - what’s new?

References

• Benziger CP, Roth GA, Moran AE. The global burden of disease study and the preventable burden of NCD. Glob Heart. 2016;00(00):393–397.
   Google Scholar
• Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37–55.
   PubMed Web of Science ®Google Scholar
• Fryar CD, Ostchega Y, Hales CM, et al. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS Data Brief. 2017 Oct;(289):1–8.
   Google Scholar
• Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the framingham heart study. JAMA. 2002;287(8):1003–1010.
   PubMed Web of Science ®Google Scholar
• Franklin SS. Elderly hypertensives: how are they different? J Clin Hypertens (Greenwich, CT). 2012;14(11):779–786.
   PubMed Web of Science ®Google Scholar
• Bavishi C, Goel S, Messerli FH. Isolated systolic hypertension: an update after SPRINT. Am J Med. 2016;129(12):1251–1258.
   PubMed Web of Science ®Google Scholar
• Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37(3):869–874.
   PubMed Web of Science ®Google Scholar
• Liu X, Rodriguez CJ, Wang K. Prevalence and trends of isolated systolic hypertension among untreated adults in the United States. J Am Soc Hypertens. 2015;9(3):197–205.
   PubMed Web of Science ®Google Scholar
• Benetos A, Thomas F, Bean K, et al. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002;162(5):577–581.
   PubMedGoogle Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255–3264.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet. 1997;350(9080):757–764.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998;16(12 Pt 1):1823–1829.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–1898.
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56(12):1683–1689.
   PubMed Web of Science ®Google Scholar
• Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487–499.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6): e13–e115
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520.
   PubMed Web of Science ®Google Scholar
• Benetos A, Bulpitt CJ, Petrovic M, et al. An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the management of hypertension in very old, frail subjects. Hypertension. 2016;67(5):820–825.
   PubMed Web of Science ®Google Scholar
• Corrao G, Mazzola P, Monzio Compagnoni M, et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-Based Cohort Study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging. 2015;32(11):927–936.
   PubMed Web of Science ®Google Scholar
• Angelousi A, Girerd N, Benetos A, et al. Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis. J Hypertens. 2014;32(8):1562–1571; discussion 1571.
   PubMed Web of Science ®Google Scholar
• Speechley M, Tinetti M. Falls and injuries in frail and vigorous community elderly persons. J Am Geriatr Soc. 1991;39(1):46–52.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Stadnyk K, MacKnight C, et al. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353(9148):205–206.
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–M156.
   PubMed Web of Science ®Google Scholar
• Gilardi F, Capanna A, Ferraro M, et al. Frailty screening and assessment tools: a review of characteristics and use in Public Health. Ann Ig. 2018;30(2):128–139.
   PubMed Web of Science ®Google Scholar
• Group SR, Wright JT Jr., Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116.
   PubMed Web of Science ®Google Scholar
• Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >/=75 Years: a randomized clinical trial. JAMA. 2016;315(24):2673–2682.
   PubMed Web of Science ®Google Scholar
• Group SPRINT, Williamson JD, Pajewski NM, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–561.
   PubMed Web of Science ®Google Scholar
• Odden MC, Peralta CA, Berlowitz DR, et al. Effect of intensive blood pressure control on gait speed and mobility limitation in adults 75 years or older: a randomized clinical trial. JAMA Intern Med. 2017;177(4):500–507.
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Lund-Johansen P, Nilsson PM, et al. Unattended blood pressure measurements in the systolic blood pressure intervention trial: implications for entry and achieved blood pressure values compared with other trials. Hypertension. 2016;67(5):808–812.
   PubMed Web of Science ®Google Scholar
• Lonn EM, Bosch J, Lopez-Jaramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2009–2020.
   PubMed Web of Science ®Google Scholar
• Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE Study. JAMA Intern Med. 2015;175(6):989–995.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
   PubMed Web of Science ®Google Scholar
• Parati G, Stergiou G, O’Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–1366.
   PubMed Web of Science ®Google Scholar
• Asayama K, Li Y, Franklin SS, et al. Cardiovascular risk associated with white-coat hypertension: con side of the argument. Hypertension. 2017;70(4):676–682.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Cuspidi C, et al. Cardiovascular risk associated with white-coat hypertension: pro side of the argument. Hypertension. 2017;70(4):668–675.
   PubMed Web of Science ®Google Scholar
• Cooney MT, Selmer R, Lindman A, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093–1103.
   PubMed Web of Science ®Google Scholar
• Cicero AFG, Colletti A, Fogacci F, et al. Is it possible to significantly modify blood pressure with a combined nutraceutical on top of a healthy diet? The results of a pilot clinical trial. High Blood Press Cardiovasc Prev. 2018;25(4):401–405.
   PubMed Web of Science ®Google Scholar
• De Vecchis R, Ariano C. Is sacubitril/valsartan safe for treatment of hypertension at any age? J Cardiovasc Med (Hagerstown). 2019;20(1):49.
   PubMed Web of Science ®Google Scholar
• Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatric Pharmacother. 2011;9(1):11–23.
   PubMed Web of Science ®Google Scholar
• Cho MH, Shin DW, Chang SA, et al. Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Sci Rep. 2018;8(1):11688.
   PubMedGoogle Scholar
• Lawes CM, Vander Hoorn S, Rodgers A. International Society of H. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–1518.
   PubMed Web of Science ®Google Scholar
• Iulita MF, Girouard H. Treating hypertension to prevent cognitive decline and dementia: re-opening the debate. Adv Exp Med Biol. 2017;956:447–473.
   PubMed Web of Science ®Google Scholar
• Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5):963–975.
   PubMed Web of Science ®Google Scholar
• Tolonen H, Giampaoli S, Kuulasmaa K, et al. Blood pressure profiles, and awareness and treatment of hypertension in Europe - results from the EHES Pilot Project. Public Health. 2016;135:135–139.
   PubMed Web of Science ®Google Scholar
• Dregan A, Ravindrarajah R, Hazra N, et al. Longitudinal trends in hypertension management and mortality among octogenarians: prospective cohort study. Hypertension. 2016;68(1):97–105.
   PubMed Web of Science ®Google Scholar
• Filipovsky J, Seidlerova J, Kratochvil Z, et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25(4):228–234.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Rich R, et al. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017;166(6):430–437.
   PubMed Web of Science ®Google Scholar
• Burnier M, Wuerzner G, Struijker-Boudier H, et al. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218–225.
   PubMed Web of Science ®Google Scholar
• Wilson L, Bhatnagar P, Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis. Popul Health Metr. 2017;15(1):23.
   PubMedGoogle Scholar
• Weir HK, Anderson RN, Coleman KSM, et al. Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020. Prev Chronic Dis. 2016;13:E157.
   PubMed Web of Science ®Google Scholar